4. This seems like an unusual application of the Karolinska Sleepiness Scale. The protocol calls for its administration in the evening and again in the morning within 2 hours of awakening. I wonder how you will interpret the results in patients with disrupted circadian rhythms. I also wonder how it might differ if the patient fills it out 15 minutes after awakening versus 90 minutes after awakening.
5. You could elaborate on the study limitations. It is a single center study. Even PSG is debatable as the gold standard of sleep measurement in ICU patients. And I agree that missing data is likely to be an issue which will also have to be elaborated if that proves to be true.
Overall, I commend the authors for planning this project. The objectives are very important and the findings could change our practice. So I will be excited to hear how the project is progressing.
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GENERAL COMMENTS
Please check the sample size. This is a proposed project to determine if sleep monitoring of ICU patients with actigraphy and subjective (nursing and patient-reporting) assessment tools correlate with PSG. The authors acknowledge that PSG is difficult to apply in the ICU especially on a large scale but that sleep is important and we currently have no reliable means to measure and monitor it. This is an ambitious project of 80 patients which would make it one of the largest PSG studies of ICU patients ever. I will be very anxious to learn of the results.
VERSION 1 -AUTHOR RESPONSE
A few comments:
1. I understand that 80 patients will be selected for inclusion. I would consider doing an interim assessment of the type of patient included. If, for example, you are past the halfway point of enrollment and the majority of patients are either mechanically ventilated or have very high APACHE scores, you may want to consider selecting the majority of the remaining subjects from a pool of less acutely ill patients. It is possible that actigraphy and/or subjective assessment may be appropriate for those less acutely ill but not for the most sick. If your enrollment is biased toward the most acutely ill patients, you may miss this conclusion.
(Authors response) The research team has considered the potential of an interim analysis, however the HREC approval for the study does not allow for an interim review and may impact of on the statistical analysis through reducing power at the conclusion of the study. The inclusion/exclusion criteria for the study which specifies the eligibility of patient to be recruited would also restrict the recruitment of the severely ill patients and as a result will more likely be under-represented rather than over represented. Rather, the pre-specified analysis will take into consideration the severity of illness based on APACH score, and if there is a variance then this may provide the basis for hypothesis generation for a future research.
2. You do not describe how you will handle atypical PSG findings which may be common in the more acutely ill patients.
(Authors response) The management of atypical PSG findings has been incorporated into the method section of the paper, and now reads:
Atypical sleep patterns are known to occur within the ICU patient cohort, which hampers the ability to interpret sleep staging based on traditional criteria. In cases where atypical PSG data is identified these will be analysed based on Watson et al's32 revised ICU sleep scoring criteria.
3. You mention that you will be documenting the use of analgosedation, antipsychotic medications, etc. Will you also collect information about hypnotic use, melatonin, etc.? Many other medications affect sleep and could affect results of actigraphy such as steroids which can also make some patients agitated.
(Authors response) The study is collecting information regarding to medication administration, particularly those medications commonly prescribed within the unit. Information regarding the use of hypnotic is also being collated along with recording a diverse range of medications the patients are prescribed. Due the recruitment numbers and likely diversity in medications used in the patient cases it not likely that there will sufficient patient numbers to make inferences around many of the medications and their impact on sleep. Administration of melatonin will be documented; however this medication is currently not prescribed to patients in the unit in which the research is being conducted.
This section has been amended and now reads:
The following variables will be collected: gender age, APACHE II score, and APACHE II diagnostic classification, continuous renal replacement therapy, type of respiratory support, length of ICU admission when sleep monitoring was commenced, the use of eye masks or ear plugs, the presence or absence of physical restraints, delirium score (Confusion Assessment Method -ICU), ICU length of stay (LOS), Hospital LOS, and mortality (alive/deceased in ICU or hospital). Further, the use of analgosedation, anti-psychotic and hypnotic medications, administration of melatonin, inotropes and vasopressors will be documented to assess the heterogeneity of the sample and enable the measurement of predictive factors.
(Authors response) The Karolinska Sleepiness Scale is being used to investigate if patients reporting subjective feeling of sleepiness results in sleep onset. There is known discordance between the subjective view of patients and their sleep duration and quality. This assessment is being used to identify if patients who report high levels of sleepiness have a shorter sleep latency or if reported sleepiness in ICU patients does not related to reduced sleep latency.
The timing of the administration within the 2 hour timeframe does not alter the subjective opinion of the individual. The reported level of subjective sleepiness based on KSS had been previously reported to correlate well with polysomnographic changes. In the setting of circadian rhythm disturbance subjective sleepiness may also be preceded by changes in sleep latency.
(Authors response) The discussion has been included a discussion regarding the study limitations. This contains the following discussion: This observational study will endeavour to ascertain the potential and ability of a motion accelerometer to accurately identify ICU patients' total sleep time and sleep fragmentation. Acquiring cost effective and easily interpretable data on ICU patients' sleep and sleep disturbances will provide clinicians with important information on which they can base clinical management strategies to enhance patients' overall wellbeing and recovery. There are however limitations associated with the study, these include it being a single centre study which may limit the generalisability of the findings, although it may provide the impetus for multi-centre studies. Further, PSG is deemed the gold standard of sleep monitoring, however its ability to monitor sleep within the Intensive Care patient cohort presents challenges in regards to the data acquired. The impact of missing data will be investigated as outlined and may further highlight the issues and complexity of sleep monitoring amongst ICU patients and the clinical feasibility of PSG monitoring. Additionally, the results of this study will enhance understandings of how and to what extent environmental factors contribute to sleep disturbance and thus provide valuable information that can be used to inform the future designs and characteristics of ICUs. The findings derived from this study will be submitted to academic peerreviewed journals for publication and presented at relevant international and national conferences. The transfer of knowledge obtained from this study will also be provided to the institution's healthcare policy makers and clinicians via seminars and study synopses to aid in the improvement of clinical care.
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Please check the sample size.
(Authors) Sample size has been reassessed with the current reported recruitment numbers providing a moderate size effect.
